Desperate for relief: one patient gets experimental stem cell infusions for chronic pain

NCT ID NCT04711811

NO_LONGER_AVAILABLE Symptom relief Sponsor: Hope Biosciences Research Foundation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial gave multiple infusions of a patient's own stem cells to treat chronic muscle and joint pain that had lasted at least a year. The patient received six infusions over about 32 weeks, with safety checks and pain scores tracked throughout. The goal was to see if this approach could safely ease pain and improve daily life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: patient's own stem cells (Hope Biosciences adipose derived autologous mesenchymal stem cells)
What this could lead to: If it works, this could point toward a way to reduce chronic pain without long-term medication.
What could go wrong: This was a very small, early access program for just one patient, so results may not apply to others. The treatment is still experimental and unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome injury Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN

Contacts and locations

Locations

Hope Biosciences Stem Cell Research Foundation

Sugar Land, Texas, 77478, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.